ISPOR

ISPOR is the leading global scientific and educational organization for health economics and outcomes research (#HEOR).

Retweets do not equal endorsements

[ISPOR @ISPORorg]

📢NEW ISSUE ALERT📢

In case you missed it... the July edition of Value in Health is out! Discover the latest peer-reviewed research in health economics and outcomes research from around the globe.

🔗 Browse the issue: https://t.co/XAq3MBVH2x

#HEOR #ValueinHealth #ISPOR

[ISPOR @ISPORorg]

Catch up on-demand! Recent webinars covered expert elicitation approaches; applying #HEOR & economic evaluation in #healthcare decisions; understanding the first JCAs; #AI in health preference research; & early integrated evidence generation planning. https://t.co/i3xEPHnyfd

[ISPOR @ISPORorg]

Relive the highlights from ISPOR 2026 and continue your learning.

Session recordings are now available in the HEOR Learning Lab. Catch up on presentations you missed or revisit key insights on demand.
➡️https://t.co/R3tEoqmmpF

#ISPORAnnual

[ISPOR @ISPORorg]

Join the global healthcare community at #ISPOREurope 2026 to explore how science and policy are shaping the future of healthcare access.

Start planning with the Schedule-at-a-Glance >> https://t.co/Rb9foW9aRL

[ISPOR @ISPORorg]

Welcome to ISPOR’s newest Board members: Sandra Nestler-Parr, William Padula, and Jing Wu. These Board members will serve as Directors for the 2026-2029 term.
https://t.co/hQQ3LAfKXE

[ISPOR @ISPORorg]

A special thank you to Dalia Dawoud, Lucinda Orsini, and Amy O’Sullivan whose term as Directors of the ISPOR Board of Directors ends. We are grateful for their service to the Society and expert guidance and support over the last few years.

[ISPOR @ISPORorg]

Congratulations and welcome to Jens Grueger, PhD, as he begins the role of ISPOR Treasurer! https://t.co/FPr9ClzfeB

[ISPOR @ISPORorg]

A special thank you to Sean D. Sullivan, BScPharm, MSc, PhD, for serving as ISPOR Treasurer from 2020-2026. Dr Sullivan’s dedication and commitment to the financial wellbeing of the Society has been invaluable.

[ISPOR @ISPORorg]

Congratulations and welcome to Lotte Steuten, PhD, MSc, as she begins the role of ISPOR President-Elect (2026-2027). https://t.co/VJVDAMgj6P

[ISPOR @ISPORorg]

Congratulations to Beth Devine, PhD, PharmD, MBA, MSc, as she moves into the role of ISPOR President (2026-2027). #HEOR #healthcare #leaders #leadership
https://t.co/X9pv0idPaf

[ISPOR @ISPORorg]

📢 New Issue Alert! 📢

The June issue of Value & Outcomes Spotlight explores drug pricing policies—from affordability and innovation to value-based pricing and global perspectives.

Read the articles👉 https://t.co/8kreXh471k

#HEOR #ValueOutcomesSpotlight #drugpricing

[ISPOR @ISPORorg]

Generating #RWE in rare diseases can be challenging with often small populations, fragmented data, and regulatory uncertainty. AI is changing that. Join us July 16 for a webinar sponsored by @Parexel. Register: https://t.co/0hyVxcp5Cs

#HEOR #RareDisease #AI

[ISPOR @ISPORorg]

ISPOR extends a heartfelt thank you to Prof. Uwe Siebert, MPH, MSc, ScD for his service as President of the Society for the 2025-2026 term. Prof. Siebert will complete his 3-year term as immediate Past-President. @UweSiebert9
https://t.co/aaDzEOlpRR

[ISPOR @ISPORorg]

Last day to apply! ISPOR is accepting applications for 4 At-Large Member positions on the Nominations Committee through tomorrow, June 30.
You can apply by clicking here: https://t.co/PAFyrSGOKq

[ISPOR @ISPORorg]

How do you move from evidence generation to decision-grade impact? Join a webinar on IEGP, including #HTA expectations, comparators, #patient data, and #RWE strategies.

Sponsored by Thermo Fisher Scientific.

Register here >> https://t.co/ndsXJGDzMD

[ISPOR @ISPORorg]

#ISPORNews - Value in Health announced publication of research papers that offer new tools to help health policy makers weigh fairness & cost-effectiveness. https://t.co/lqpL58hnSc

[ISPOR @ISPORorg]

Last chance! Research abstract submissions for #ISPOREurope 2026 close 26 June. Share your work with the global #HEOR community and contribute to discussions shaping the future of #healthcare.

Submit now >> https://t.co/XIPPh3Dp25

[ISPOR @ISPORorg]

How are policy, pricing, and evidence requirements shaping healthcare investment decisions? Explore the program for the ISPOR Healthcare Investment Summit 2026!

Register by August 13 to save 15%.
https://t.co/8U4L1EmB7w

#ISPORSummit #HEOR #Healthcare

[ISPOR @ISPORorg]

Happening soon ⏳

Explore how AI is transforming health preference research—from evidence synthesis to predicting patient preferences.

Join us this week to see what’s next.
🔗 https://t.co/MtZPZ0dH7E

[ISPOR @ISPORorg]

#ISPORNews - Value in Health announced the publication of an ISPOR Good Practices Report outlining 9 areas to strengthen the robustness, transparency, and feasibility of real-world patient-reported outcomes studies. Learn more: https://t.co/fRBJuShud3